LondonA rare gene defect is now treatable in children.
GATA2 haploinsufficiency wrecks the immune system and drives leukemia; a busulfan-based conditioning regimen let transplants succeed even in advanced cases, researchers report.
Early transplantation in young patients may improve outcomes further, the study’s authors say.
Sources: Nature